Navigation Links
NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds
Date:4/22/2009

New Collaboration with Leading Researchers having Clinical Experience with Antimicrobials that are Biological Basis for Aganocide Compounds

EMERYVILLE, Calif., April 22 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY), a mid-stage biopharmaceutical company developing first-in-class, potent, well-tolerated products to treat and prevent a wide range of infections with low chance of developing drug resistance, today announced an exclusive agreement with Professors Markus Nagl M.D. and Waldemar Gottardi, Ph.D. of the Medical University of Innsbruck, Austria. The agreement was entered into to advance the development of NovaBay's Aganocide compounds by integrating extensive and on-going clinical work at the university with NovaBay's development program.

Professors Gottardi and Nagl have conducted extensive clinical research and have patented and published widely for many years on the use of N-chlorotaurine (NCT), a natural antimicrobial produced by the body's white blood cells. NovaBay's Aganocide compounds are synthetic analogs of NCT that maintain or enhance the biological activity of the natural compound while adding pharmaceutically acceptable stability. Professors Gottardi and Nagl have pioneered the exploratory use of NCT compounds in humans in a number of indications that overlap with and even go beyond those for which NovaBay's Aganocide compounds are currently being developed.

Under the terms of the agreement, NovaBay will fund ongoing research in the laboratories of Professors Gottardi and Nagl at the Medical University of Innsbruck and NovaBay will have access to past and future data generated in human clinical trials by Professors Nagl, Gottardi and their collaborators. These data are expected to support many of the indications being pursued by NovaBay and its partners. For instan
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014 ... global knowledge leader in healthcare technology, media and ... healthcare innovation in China ... technologies. Continua and BHG announced this new partnership ... this week in Washington, DC ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... June 22, 2011 Life Technologies Corporation ... that the company has led a successful consortium ... the Oxford NIHR Biomedical Research Centre, AstraZeneca, and ... Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ...
... June 22, 2011 Reportlinker.com announces that ... in its catalogue: U.S. ... http://www.reportlinker.com/p0559270/US-Urinary-Incontinence-Devices.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Food_Ingredient This research ... incontinence device market. The urinary incontinence device ...
Cached Medicine Technology:Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 2Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 3Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 4Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 5Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 6Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 7Reportlinker Adds U.S. Urinary Incontinence Devices 2Reportlinker Adds U.S. Urinary Incontinence Devices 3Reportlinker Adds U.S. Urinary Incontinence Devices 4
(Date:9/22/2014)... September 19, 2014 -- Recent two-generation approaches to ... are receiving increasing attention from researchers, advocates, and ... to enable them to move to jobs that ... early care and education for children, these programs ... However, according to a new report from ...
(Date:9/22/2014)... RESTON, Va. (PRWEB) September 22, 2014 ... (WEDI), the nation’s leading nonprofit authority on ... in healthcare information exchange, announced findings from its ... unique Health Plan Identifier (HPID) within electronic transactions ... Act (HIPAA). WEDI conducted the survey from August ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... What can I do to help ensure a healthy baby? ... may play a role in reducing the risk of having ... found that mothers of children with autism were significantly less ... than those whose children seem to be developing normally. ...
(Date:9/22/2014)... 2014 Severe weather can occur with little warning, ... as part of National Preparedness Month, Amica Insurance is ... for the unexpected:, , Build an emergency supply ... and one gallon of water per person per day for at ... plan that includes pets so your family knows what to do ...
(Date:9/22/2014)... The struggles that lie in communication between ... been well-documented—reportedly, language barriers between doctors and patients are ... room and an increased likelihood for fatal consequences and ... the largest medical facility in the Fargo, ND and ... the need for Video Remote Interpreting (VRI), ...
Breaking Medicine News(10 mins):Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:Amica Shares Tips for National Preparedness Month 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... LONDON: Children who attend day care or play groups ... most common type of childhood leukaemia than those who ... investigating the link. , The new research, to ... Causes and Prevention of Childhood Leukaemia Conference in London, ...
... Retire from Company -, LAVAL, QC, April ... today announced that Claire Brulle, M.D. has been ... Company. Incumbent,Chief Medical Officer Dr. Sylvie Bouchard has ... practicing medicine., "Dr. Brulle brings to Labopharm ...
... Authentidate,Holding Corp. (Nasdaq: ADAT ), ... and web-based services, today announced that United,Seating ... providers of comprehensive,seating and mobility solutions for ... platform from Authentidate(R) to facilitate its,mobility provisioning ...
... TRIANGLE PARK, N.C., April 28 Tryton Medical,Inc. ... Davis as President and,Chief Executive Officer. Founded in ... that are designed to definitively treat bifurcation,lesions., ... 20-year career with,Guidant and Eli Lilly & Company. ...
... (Oakland, Calif.) Diabetes before motherhood more than doubled ... to a Kaiser Permanente study published in the May ... previous studies have looked exclusively at gestational diabetes (diabetes ... baby is born), this is the largest and most ...
... the Universities of Exeter and Coventry have developed the ... the rapid diagnostic tests (RDTs) currently used in the ... suggest that the technique could be as effective as ... potentially viable alternative. The team is now working on ...
Cached Medicine News:Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 3Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 4Health News:J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc. 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 3Health News:Exeter engineers create new technique for malaria diagnosis 2